Global Proton Pump Inhibitors for Gastric Acid Therapy Supply, Demand and Key Producers, 2024-2030
Page: 132
Published Date: 13 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Proton Pump Inhibitors for Gastric Acid Therapy market size is expected to reach $ 9745.2 million by 2030, rising at a market growth of -3.1% CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
This report studies the global Proton Pump Inhibitors for Gastric Acid Therapy production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Proton Pump Inhibitors for Gastric Acid Therapy, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Proton Pump Inhibitors for Gastric Acid Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Proton Pump Inhibitors for Gastric Acid Therapy total production and demand, 2019-2030, (K Units)
Global Proton Pump Inhibitors for Gastric Acid Therapy total production value, 2019-2030, (USD Million)
Global Proton Pump Inhibitors for Gastric Acid Therapy production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Proton Pump Inhibitors for Gastric Acid Therapy consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Proton Pump Inhibitors for Gastric Acid Therapy domestic production, consumption, key domestic manufacturers and share
Global Proton Pump Inhibitors for Gastric Acid Therapy production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Proton Pump Inhibitors for Gastric Acid Therapy production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Proton Pump Inhibitors for Gastric Acid Therapy production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Proton Pump Inhibitors for Gastric Acid Therapy market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, Pfizer, AstraZeneca, Bayer, Sun Pharma, Teva, Eisai Co., Mylan and AOSAIKANG Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Proton Pump Inhibitors for Gastric Acid Therapy market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Proton Pump Inhibitors for Gastric Acid Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Proton Pump Inhibitors for Gastric Acid Therapy Market, Segmentation by Type
Dexlansoprazole
Esomeprazole
Lansoprazole
Omeprazole
Pantoprazole
Rabeprazole
Global Proton Pump Inhibitors for Gastric Acid Therapy Market, Segmentation by Application
Hospital Pharmacy
Retail Pharmacy
Other
Companies Profiled:
Takeda
Pfizer
AstraZeneca
Bayer
Sun Pharma
Teva
Eisai Co.
Mylan
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Key Questions Answered
1. How big is the global Proton Pump Inhibitors for Gastric Acid Therapy market?
2. What is the demand of the global Proton Pump Inhibitors for Gastric Acid Therapy market?
3. What is the year over year growth of the global Proton Pump Inhibitors for Gastric Acid Therapy market?
4. What is the production and production value of the global Proton Pump Inhibitors for Gastric Acid Therapy market?
5. Who are the key producers in the global Proton Pump Inhibitors for Gastric Acid Therapy market?
Table of Contents
1 Supply Summary
1.1 Proton Pump Inhibitors for Gastric Acid Therapy Introduction
1.2 World Proton Pump Inhibitors for Gastric Acid Therapy Supply & Forecast
1.2.1 World Proton Pump Inhibitors for Gastric Acid Therapy Production Value (2019 & 2023 & 2030)
1.2.2 World Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030)
1.2.3 World Proton Pump Inhibitors for Gastric Acid Therapy Pricing Trends (2019-2030)
1.3 World Proton Pump Inhibitors for Gastric Acid Therapy Production by Region (Based on Production Site)
1.3.1 World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Region (2019-2030)
1.3.2 World Proton Pump Inhibitors for Gastric Acid Therapy Production by Region (2019-2030)
1.3.3 World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Region (2019-2030)
1.3.4 North America Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030)
1.3.5 Europe Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030)
1.3.6 China Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030)
1.3.7 Japan Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Proton Pump Inhibitors for Gastric Acid Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Proton Pump Inhibitors for Gastric Acid Therapy Major Market Trends
2.1 World Proton Pump Inhibitors for Gastric Acid Therapy Demand (2019-2030)
2.2 World Proton Pump Inhibitors for Gastric Acid Therapy Consumption by Region
2.2.1 World Proton Pump Inhibitors for Gastric Acid Therapy Consumption by Region (2019-2024)
2.2.2 World Proton Pump Inhibitors for Gastric Acid Therapy Consumption Forecast by Region (2025-2030)
2.3 United States Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030)
2.4 China Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030)
2.5 Europe Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030)
2.6 Japan Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030)
2.7 South Korea Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030)
2.8 ASEAN Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030)
2.9 India Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030)
3.1 World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Manufacturer (2019-2024)
3.2 World Proton Pump Inhibitors for Gastric Acid Therapy Production by Manufacturer (2019-2024)
3.3 World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Manufacturer (2019-2024)
3.4 Proton Pump Inhibitors for Gastric Acid Therapy Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Proton Pump Inhibitors for Gastric Acid Therapy in 2023
3.5.3 Global Concentration Ratios (CR8) for Proton Pump Inhibitors for Gastric Acid Therapy in 2023
3.6 Proton Pump Inhibitors for Gastric Acid Therapy Market: Overall Company Footprint Analysis
3.6.1 Proton Pump Inhibitors for Gastric Acid Therapy Market: Region Footprint
3.6.2 Proton Pump Inhibitors for Gastric Acid Therapy Market: Company Product Type Footprint
3.6.3 Proton Pump Inhibitors for Gastric Acid Therapy Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Production Value Comparison
4.1.1 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Production Comparison
4.2.1 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Consumption Comparison
4.3.1 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value (2019-2024)
4.4.3 United States Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2024)
4.5 China Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers and Market Share
4.5.1 China Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value (2019-2024)
4.5.3 China Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2024)
4.6 Rest of World Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2024)
5.1 World Proton Pump Inhibitors for Gastric Acid Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Dexlansoprazole
5.2.2 Esomeprazole
5.2.3 Lansoprazole
5.2.4 Omeprazole
5.2.5 Pantoprazole
5.2.6 Rabeprazole
5.3 Market Segment by Type
5.3.1 World Proton Pump Inhibitors for Gastric Acid Therapy Production by Type (2019-2030)
5.3.2 World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Type (2019-2030)
5.3.3 World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Type (2019-2030)
6.1 World Proton Pump Inhibitors for Gastric Acid Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Proton Pump Inhibitors for Gastric Acid Therapy Production by Application (2019-2030)
6.3.2 World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Application (2019-2030)
6.3.3 World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Application (2019-2030)
7.1 Takeda
7.1.1 Takeda Details
7.1.2 Takeda Major Business
7.1.3 Takeda Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.1.4 Takeda Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Takeda Recent Developments/Updates
7.1.6 Takeda Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.2.4 Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.3.4 AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Bayer
7.4.1 Bayer Details
7.4.2 Bayer Major Business
7.4.3 Bayer Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.4.4 Bayer Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Bayer Recent Developments/Updates
7.4.6 Bayer Competitive Strengths & Weaknesses
7.5 Sun Pharma
7.5.1 Sun Pharma Details
7.5.2 Sun Pharma Major Business
7.5.3 Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.5.4 Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Sun Pharma Recent Developments/Updates
7.5.6 Sun Pharma Competitive Strengths & Weaknesses
7.6 Teva
7.6.1 Teva Details
7.6.2 Teva Major Business
7.6.3 Teva Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.6.4 Teva Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Teva Recent Developments/Updates
7.6.6 Teva Competitive Strengths & Weaknesses
7.7 Eisai Co.
7.7.1 Eisai Co. Details
7.7.2 Eisai Co. Major Business
7.7.3 Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.7.4 Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Eisai Co. Recent Developments/Updates
7.7.6 Eisai Co. Competitive Strengths & Weaknesses
7.8 Mylan
7.8.1 Mylan Details
7.8.2 Mylan Major Business
7.8.3 Mylan Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.8.4 Mylan Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Mylan Recent Developments/Updates
7.8.6 Mylan Competitive Strengths & Weaknesses
7.9 AOSAIKANG Pharma
7.9.1 AOSAIKANG Pharma Details
7.9.2 AOSAIKANG Pharma Major Business
7.9.3 AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.9.4 AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 AOSAIKANG Pharma Recent Developments/Updates
7.9.6 AOSAIKANG Pharma Competitive Strengths & Weaknesses
7.10 Luoxin Pharma
7.10.1 Luoxin Pharma Details
7.10.2 Luoxin Pharma Major Business
7.10.3 Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.10.4 Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Luoxin Pharma Recent Developments/Updates
7.10.6 Luoxin Pharma Competitive Strengths & Weaknesses
7.11 LIVZON
7.11.1 LIVZON Details
7.11.2 LIVZON Major Business
7.11.3 LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.11.4 LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 LIVZON Recent Developments/Updates
7.11.6 LIVZON Competitive Strengths & Weaknesses
7.12 Eastchina Pharma
7.12.1 Eastchina Pharma Details
7.12.2 Eastchina Pharma Major Business
7.12.3 Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
7.12.4 Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Eastchina Pharma Recent Developments/Updates
7.12.6 Eastchina Pharma Competitive Strengths & Weaknesses
8.1 Proton Pump Inhibitors for Gastric Acid Therapy Industry Chain
8.2 Proton Pump Inhibitors for Gastric Acid Therapy Upstream Analysis
8.2.1 Proton Pump Inhibitors for Gastric Acid Therapy Core Raw Materials
8.2.2 Main Manufacturers of Proton Pump Inhibitors for Gastric Acid Therapy Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Proton Pump Inhibitors for Gastric Acid Therapy Production Mode
8.6 Proton Pump Inhibitors for Gastric Acid Therapy Procurement Model
8.7 Proton Pump Inhibitors for Gastric Acid Therapy Industry Sales Model and Sales Channels
8.7.1 Proton Pump Inhibitors for Gastric Acid Therapy Sales Model
8.7.2 Proton Pump Inhibitors for Gastric Acid Therapy Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Region (2019-2024) & (USD Million)
Table 3. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Region (2025-2030) & (USD Million)
Table 4. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share by Region (2019-2024)
Table 5. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share by Region (2025-2030)
Table 6. World Proton Pump Inhibitors for Gastric Acid Therapy Production by Region (2019-2024) & (K Units)
Table 7. World Proton Pump Inhibitors for Gastric Acid Therapy Production by Region (2025-2030) & (K Units)
Table 8. World Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share by Region (2019-2024)
Table 9. World Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share by Region (2025-2030)
Table 10. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Proton Pump Inhibitors for Gastric Acid Therapy Major Market Trends
Table 13. World Proton Pump Inhibitors for Gastric Acid Therapy Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Proton Pump Inhibitors for Gastric Acid Therapy Consumption by Region (2019-2024) & (K Units)
Table 15. World Proton Pump Inhibitors for Gastric Acid Therapy Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Proton Pump Inhibitors for Gastric Acid Therapy Producers in 2023
Table 18. World Proton Pump Inhibitors for Gastric Acid Therapy Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Proton Pump Inhibitors for Gastric Acid Therapy Producers in 2023
Table 20. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Proton Pump Inhibitors for Gastric Acid Therapy Company Evaluation Quadrant
Table 22. World Proton Pump Inhibitors for Gastric Acid Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Proton Pump Inhibitors for Gastric Acid Therapy Production Site of Key Manufacturer
Table 24. Proton Pump Inhibitors for Gastric Acid Therapy Market: Company Product Type Footprint
Table 25. Proton Pump Inhibitors for Gastric Acid Therapy Market: Company Product Application Footprint
Table 26. Proton Pump Inhibitors for Gastric Acid Therapy Competitive Factors
Table 27. Proton Pump Inhibitors for Gastric Acid Therapy New Entrant and Capacity Expansion Plans
Table 28. Proton Pump Inhibitors for Gastric Acid Therapy Mergers & Acquisitions Activity
Table 29. United States VS China Proton Pump Inhibitors for Gastric Acid Therapy Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Proton Pump Inhibitors for Gastric Acid Therapy Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Proton Pump Inhibitors for Gastric Acid Therapy Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share (2019-2024)
Table 37. China Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share (2019-2024)
Table 42. Rest of World Based Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share (2019-2024)
Table 47. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Proton Pump Inhibitors for Gastric Acid Therapy Production by Type (2019-2024) & (K Units)
Table 49. World Proton Pump Inhibitors for Gastric Acid Therapy Production by Type (2025-2030) & (K Units)
Table 50. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Type (2019-2024) & (USD Million)
Table 51. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Type (2025-2030) & (USD Million)
Table 52. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Proton Pump Inhibitors for Gastric Acid Therapy Production by Application (2019-2024) & (K Units)
Table 56. World Proton Pump Inhibitors for Gastric Acid Therapy Production by Application (2025-2030) & (K Units)
Table 57. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Application (2019-2024) & (USD Million)
Table 58. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Application (2025-2030) & (USD Million)
Table 59. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Major Business
Table 63. Takeda Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 64. Takeda Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Takeda Recent Developments/Updates
Table 66. Takeda Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 70. Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 76. AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. Bayer Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Major Business
Table 81. Bayer Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 82. Bayer Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Bayer Recent Developments/Updates
Table 84. Bayer Competitive Strengths & Weaknesses
Table 85. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Sun Pharma Major Business
Table 87. Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 88. Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Sun Pharma Recent Developments/Updates
Table 90. Sun Pharma Competitive Strengths & Weaknesses
Table 91. Teva Basic Information, Manufacturing Base and Competitors
Table 92. Teva Major Business
Table 93. Teva Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 94. Teva Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Teva Recent Developments/Updates
Table 96. Teva Competitive Strengths & Weaknesses
Table 97. Eisai Co. Basic Information, Manufacturing Base and Competitors
Table 98. Eisai Co. Major Business
Table 99. Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 100. Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Eisai Co. Recent Developments/Updates
Table 102. Eisai Co. Competitive Strengths & Weaknesses
Table 103. Mylan Basic Information, Manufacturing Base and Competitors
Table 104. Mylan Major Business
Table 105. Mylan Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 106. Mylan Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Mylan Recent Developments/Updates
Table 108. Mylan Competitive Strengths & Weaknesses
Table 109. AOSAIKANG Pharma Basic Information, Manufacturing Base and Competitors
Table 110. AOSAIKANG Pharma Major Business
Table 111. AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 112. AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. AOSAIKANG Pharma Recent Developments/Updates
Table 114. AOSAIKANG Pharma Competitive Strengths & Weaknesses
Table 115. Luoxin Pharma Basic Information, Manufacturing Base and Competitors
Table 116. Luoxin Pharma Major Business
Table 117. Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 118. Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Luoxin Pharma Recent Developments/Updates
Table 120. Luoxin Pharma Competitive Strengths & Weaknesses
Table 121. LIVZON Basic Information, Manufacturing Base and Competitors
Table 122. LIVZON Major Business
Table 123. LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 124. LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. LIVZON Recent Developments/Updates
Table 126. Eastchina Pharma Basic Information, Manufacturing Base and Competitors
Table 127. Eastchina Pharma Major Business
Table 128. Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product and Services
Table 129. Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 130. Global Key Players of Proton Pump Inhibitors for Gastric Acid Therapy Upstream (Raw Materials)
Table 131. Proton Pump Inhibitors for Gastric Acid Therapy Typical Customers
Table 132. Proton Pump Inhibitors for Gastric Acid Therapy Typical Distributors
List of Figure
Figure 1. Proton Pump Inhibitors for Gastric Acid Therapy Picture
Figure 2. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030) & (K Units)
Figure 5. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price (2019-2030) & (US$/Unit)
Figure 6. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share by Region (2019-2030)
Figure 7. World Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share by Region (2019-2030)
Figure 8. North America Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030) & (K Units)
Figure 9. Europe Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030) & (K Units)
Figure 10. China Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030) & (K Units)
Figure 11. Japan Proton Pump Inhibitors for Gastric Acid Therapy Production (2019-2030) & (K Units)
Figure 12. Proton Pump Inhibitors for Gastric Acid Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030) & (K Units)
Figure 15. World Proton Pump Inhibitors for Gastric Acid Therapy Consumption Market Share by Region (2019-2030)
Figure 16. United States Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030) & (K Units)
Figure 17. China Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030) & (K Units)
Figure 18. Europe Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030) & (K Units)
Figure 19. Japan Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030) & (K Units)
Figure 20. South Korea Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030) & (K Units)
Figure 22. India Proton Pump Inhibitors for Gastric Acid Therapy Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Proton Pump Inhibitors for Gastric Acid Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Proton Pump Inhibitors for Gastric Acid Therapy Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Proton Pump Inhibitors for Gastric Acid Therapy Markets in 2023
Figure 26. United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Proton Pump Inhibitors for Gastric Acid Therapy Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share 2023
Figure 30. China Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share 2023
Figure 32. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share by Type in 2023
Figure 34. Dexlansoprazole
Figure 35. Esomeprazole
Figure 36. Lansoprazole
Figure 37. Omeprazole
Figure 38. Pantoprazole
Figure 39. Rabeprazole
Figure 40. World Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share by Type (2019-2030)
Figure 41. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share by Type (2019-2030)
Figure 42. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Type (2019-2030) & (US$/Unit)
Figure 43. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 44. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share by Application in 2023
Figure 45. Hospital Pharmacy
Figure 46. Retail Pharmacy
Figure 47. Other
Figure 48. World Proton Pump Inhibitors for Gastric Acid Therapy Production Market Share by Application (2019-2030)
Figure 49. World Proton Pump Inhibitors for Gastric Acid Therapy Production Value Market Share by Application (2019-2030)
Figure 50. World Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Application (2019-2030) & (US$/Unit)
Figure 51. Proton Pump Inhibitors for Gastric Acid Therapy Industry Chain
Figure 52. Proton Pump Inhibitors for Gastric Acid Therapy Procurement Model
Figure 53. Proton Pump Inhibitors for Gastric Acid Therapy Sales Model
Figure 54. Proton Pump Inhibitors for Gastric Acid Therapy Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Takeda Pfizer AstraZeneca Bayer Sun Pharma Teva Eisai Co. Mylan AOSAIKANG Pharma Luoxin Pharma LIVZON Eastchina Pharma
Related Reports
26 Nov 2022
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
